Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04543110 |
| Title | Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC (RADIANT) |
| Acronym | RADIANT |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Ottawa Hospital Research Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cross Cancer Institute | RECRUITING | Edmonton | Alberta | Canada | Details | |
| Juravinski Cancer Centre | RECRUITING | Hamilton | Ontario | Canada | Details | |
| London Health Sciences Centre | RECRUITING | London | Ontario | Canada | Details | |
| The Ottawa Hospital Cancer Centre | RECRUITING | Ottawa | Ontario | K1H8L6 | Canada | Details |